Discrimination Between Sjögren's and Non-Sjögren's Sicca Syndrome by Sialoscintigraphy and Antibodies Against α-Fodrin and Ro/La Autoantigens

Author： Chen K-S Jiang M-C Li C-J Liu O-K Tsai C-SS

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.37, Iss.4, 2009-07, pp. : 1088-1096

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sjögren's syndrome

By Amarasena Roshan Bowman Simon

Clinical Medicine, Vol. 7, Iss. 1, 2007-01 ,pp. : 53-56

Royal College Of Physicians

Access to resources Recommend Favorite

Emerging biotherapies for Sjögren's syndrome

By Tobón Gabriel J Saraux Alain Pers Jacques-Olivier Youinou Pierre

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 269-282

Informa Healthcare

Access to resources Recommend Favorite

Targeting IL-1 in Sjögren's syndrome

By Yamada Akiko Arakaki Rieko Kudo Yasusei Ishimaru Naozumi

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 4, 2013-04 ,pp. : 393-401

Informa Healthcare

Access to resources Recommend Favorite

Biologic Therapies in Primary Sjogren's Syndrome

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. : 1997-2008

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome

By Bremond-Gignac Dominique Gicquel Jean-Jacques Chiambaretta Frédéric

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 6, 2014-06 ,pp. : 905-913

Informa Healthcare

Access to resources Recommend Favorite